Comparison Between Bilateral Infraorbital Block Versus Intranasal Bupivacaine in Transsphenoidal Pituitary Adenoma Resection
Clinical trial NCT05301634 · COMPLETED
Trial details
- NCT number
- NCT05301634
- Sponsor
- Cairo University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-02
- Primary completion
- 2025-07-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.